Li Kang Biomedical Co Ltd (6242) — Tangible Net Worth Ratio
Li Kang Biomedical Co Ltd (6242) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets (NT$0.00) from net assets (NT$881.47 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Li Kang Biomedical Co Ltd to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Li Kang Biomedical Co Ltd Tangible Net Worth Ratio (2002–2025)
This chart shows how Li Kang Biomedical Co Ltd's Tangible Net Worth Ratio has changed across 24 annual periods from 2002 to 2025. As of March 2026, the ratio stands at 100.0%, reflecting net assets of NT$881.47 Million with intangible assets of NT$0.00 TWD. For live market cap and overall valuation, see Li Kang Biomedical Co Ltd (6242) total market value.
Annual Tangible Net Worth Ratio for Li Kang Biomedical Co Ltd (2002–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Li Kang Biomedical Co Ltd from 2002 to 2025, covering 24 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore how much does Li Kang Biomedical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (TWD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | NT$871.24 Million | NT$0.00 | NT$1.09 Billion | ▲ +0.0 pp |
| 2024 | 100.0% | NT$855.68 Million | NT$0.00 | NT$1.04 Billion | ▲ +0.0 pp |
| 2023 | 100.0% | NT$630.03 Million | NT$0.00 | NT$827.00 Million | ▲ +0.0 pp |
| 2022 | 100.0% | NT$570.14 Million | NT$0.00 | NT$688.84 Million | ▲ +0.0 pp |
| 2021 | 100.0% | NT$492.00 Million | NT$0.00 | NT$616.07 Million | ▲ +0.0 pp |
| 2020 | 100.0% | NT$508.30 Million | NT$0.00 | NT$644.77 Million | ▲ +0.0 pp |
| 2019 | 100.0% | NT$483.44 Million | NT$203.00K | NT$626.44 Million | ▲ +0.0 pp |
| 2018 | 99.9% | NT$466.92 Million | NT$409.00K | NT$609.85 Million | ▲ +0.0 pp |
| 2017 | 99.9% | NT$445.68 Million | NT$547.00K | NT$596.06 Million | ▲ +0.1 pp |
| 2016 | 99.8% | NT$340.80 Million | NT$686.00K | NT$554.77 Million | ▲ +0.2 pp |
| 2015 | 99.6% | NT$280.29 Million | NT$1.20 Million | NT$526.73 Million | ▲ +0.3 pp |
| 2014 | 99.3% | NT$227.44 Million | NT$1.69 Million | NT$324.37 Million | ▲ +2.2 pp |
| 2013 | 97.1% | NT$24.29 Million | NT$704.00K | NT$111.79 Million | ▼ -2.9 pp |
| 2012 | 100.0% | NT$85.12 Million | NT$0.00 | NT$147.57 Million | ▲ +0.0 pp |
| 2011 | 100.0% | NT$123.43 Million | NT$0.00 | NT$182.81 Million | ▲ +0.0 pp |
| 2010 | 100.0% | NT$104.31 Million | NT$0.00 | NT$153.96 Million | ▲ +0.0 pp |
| 2009 | 100.0% | NT$128.49 Million | NT$0.00 | NT$252.83 Million | ▲ +0.0 pp |
| 2008 | 100.0% | NT$191.32 Million | NT$0.00 | NT$438.89 Million | ▲ +0.0 pp |
| 2007 | 100.0% | NT$411.54 Million | NT$0.00 | NT$701.86 Million | ▲ +0.0 pp |
| 2006 | 100.0% | NT$215.94 Million | NT$0.00 | NT$757.63 Million | ▲ +0.0 pp |
| 2005 | 100.0% | NT$223.45 Million | NT$0.00 | NT$791.11 Million | ▲ +0.0 pp |
| 2004 | 100.0% | NT$323.44 Million | NT$0.00 | NT$766.35 Million | ▲ +0.0 pp |
| 2003 | 100.0% | NT$338.06 Million | NT$0.00 | NT$770.15 Million | ▲ +0.0 pp |
| 2002 | 100.0% | NT$347.64 Million | NT$0.00 | NT$765.96 Million | — |